Way Towards New Life
Neurological Disorders Medications
Get access to an unapproved drug for personal use.
Here is a list of some of the Anti-Cancer Drugs for Neurological Disorders for which we currently have a NPP in place. If you are a patient or healthcare professional, please click below on each to access details and information.
EVRYSDI (risdiplam) for oral solution
FABRAZYME (agalsidase beta) for injection
KESIMPTA (ofatumumab) injection
LOKELMA (sodium zirconium cyclosilicate)
RELYVRIO (sodium phenylbutyrate and taurursodiol)
RXULTI (brexpiprazole) tablet
TAKHZYRO (lanadelumab) for injection
UNITUXIN (dinutuximab) injection
For Indian Patient Enquiry under NPP.
For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.
Access Under Named Patient Programs
Specialty Drugs
Here is a list of some of the products for which we currently have a NPP in place. If you are a patient or healthcare professional, please click below on each to access details and information.
XERMELO (telotristat ethyl) tablets
INGREZZA (valbenazine) capsules
TAKHZYRO (lanadelumab) for injection
Query Form
We would love to speak with you.
Feel free to reach out using the below details.
Access Unauthorized Medicines In India Under NPP.
What is Named-patient access programme (NPP)?
Named-patient basis access can also refer to a medicine for a specific patient or patients that is not (yet) authorised and available to them in their own country. Such medicine should or must (depending on legislation) be authorised in at least one country, from which it can be imported into the patient’s country under a Named-patient access programme (NPP).
These may be medicines that are:
- Authorised but not yet available to be prescribed in the patient’s country.
- Authorised and available in one country but not authorised and available in the patient’s country.
- Discontinued in the patient’s country but not in another country.
- In shortage in the patient’s country but not in another country.
Antibiotic
Arthritis
Diabetes
Genetics
Disorders
Hepatitis C
Hematologic Cancers
HIV/AIDS
Immunological Disorders
Liver Disease
Multiple Sclerosis
Nerver Disease
Oncology
Parkinson's Disease
Rare Disease
Soft Tissue Sarcoma
Transplant
Specialty Drugs
Get Access to an Unapproved Drug
Get access to an unapproved drug for personal use to following cities in India – Ahmedabad, Aizawal, Aurangabad, Barshi, Bengaluru, Bhopal, Cachar, Chennai, Dibrugarh, Hyderabad, Karungapally, Kohima, Kollam, Kolkata, Mumbai, Meghalaya, Mizoram, Sikkim, Nagpur, New Delhi, Pondichery, Pune, Punjab, Thirunananthapuram, Tripura, Wardha
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners. Alleviare provides only information & in any way, does not lay any claim on these brand names &/or trademarks.
